Novel Compound Opens New Avenue in Immunotherapy Treatment for Cancers
Researchers at the UF Health Cancer Center have developed a first-of-it-kind compound that may reveal a new way to treat cancer using immunotherapy. Currently, immunotherapy is among the most groundbreaking cancer treatments, but only about 20% to 40% of patients respond to it. It works by first identifying a target protein that contributes to tumor development and then developing a compound that will target that protein specifically, slowing tumor growth and boosting the body's immune system to fight off the cancer.
Genetic Score Advances Personalized Treatment Strategies With Promising AML Drug
In the latest development in precision medicine approaches to treating pediatric leukemia, UF Health researchers have developed a genetic score to predict patient outcomes with a promising targeted drug treatment.
University of Florida To Launch Space Mission Institute With $2.5 Million in Strategic Funding
Faculty at the University of Florida are joining forces to form the UF Space Mission Institute, with $2.5 million in funding from UF President Ben Sasse. The Institute will be managed by UF Research and will be a hub in which scientists and scholars from across UF can collaborate, conduct research, and innovate.
The institute will work to enhance existing relationships with Space Florida and the Space Life Sciences Laboratory at the Kennedy Space Center, and seek new partnerships with the International Space Station National Laboratory. The institute will also work to leverage UF’s proximity to the growing commercial space ecosystem in Florida. Throughout the next five years, the total economic impact of the commercial space industry in Florida is expected to be more than $5.3 billion.
Tech Tuesday – Mei He
In this week's Tech Tuesday for WCJB TV20, UF Innovate's Melanie Morón interviews Mei He, associate professor in the UF College of Pharmacy. Her research focuses on advancing the delivery of drugs to the human body.
By utilizing naturally-derived materials, the drug delivery process is more efficient and the drug's efficacy is maximized.
President’s Office Announces $10.2 Million for Fourth Round of Strategic Funding Awardees
The UF President's Office recently announced a fourth round of strategic funding to grow UF's research capabilities in critical areas of AI, space exploration, healthcare, and more.
Combination of Two Common Compounds Improves COVID Survival in Mice, UF Researchers Find
Researchers at the University of Florida have discovered the combination of Lactoferrin, a protein found in cow and human milk, and diphenhydramine, an antihistamine used for allergy symptoms, increased resilience of mice towards the virus that causes COVID-19.
President’s Office Announces $10.9 Million for Third Round of Strategic Funding Awardees
UF President Ben Sasse announced a third round of strategic funding, which will see $10.9 million spread across 10 new projects aimed at solidifying UF's standing as a national research leader.
Combination of Two Common Compounds Improves COVID Survival in Mice, UF Researchers Find
UF researchers have discovered a combination of two over-the-counter compounds that may significantly improve the recovery of patients infected with COVID-19. Studies in mice have been successful, with the health of test subjects improving significantly or ending in full recovery.
UF Discovery Could Lead to Earlier Pancreatic Cancer Treatments
Pancreatic cancer’s stealth-like nature has the attention of University of Florida scientists, who have discovered a way to reverse a key cellular process involved in its progression.
Scientists Hone In on Treatment for Stimulant Use Disorder
University of Florida researchers have received a $19 million grant to tackle the growing problem of stimulant use disorder.
